KLK3 and adrenal cortex adenoma: Patients with adrenal metastases exhibited significantly higher prostate-specific antigen (PSA) levels (mean: 45.6 ± 12.4 ng/mL) compared to those with benign adrenal adenomas (mean: 18.3 ± 6.7 ng/mL) (p < 0.01).